122 related articles for article (PubMed ID: 37794533)
1. An evaluation of ursodeoxycholic acid treatment in prolonged unconjugated hyperbilirubinemia due to breast milk.
Ozdemir A; Kurtoglu S; Halis H; Bastug O
Niger J Clin Pract; 2023 Sep; 26(9):1226-1233. PubMed ID: 37794533
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effects of different doses of ursodeoxycholic acid on neonatal jaundice.
Gharehbaghi MM; Sani AM; Refeey M
Turk J Pediatr; 2020; 62(3):424-430. PubMed ID: 32558416
[TBL] [Abstract][Full Text] [Related]
3. Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.
Maruo Y; Nishizawa K; Sato H; Sawa H; Shimada M
Pediatrics; 2000 Nov; 106(5):E59. PubMed ID: 11061796
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis.
Kuitunen I; Kiviranta P; Sankilampi U; Renko M
World J Pediatr; 2022 Sep; 18(9):589-597. PubMed ID: 35689782
[TBL] [Abstract][Full Text] [Related]
5. [Arias icterus--prolonged unconjugated hyperbilirubinemia caused by breast milk].
Mladenović M; Radlović N; Ristić D; Leković Z; Radlović P; Pavlović M; Gajić M; Puskarević M; Davidović I; Djurdjević J
Srp Arh Celok Lek; 2007; 135 11-12():655-8. PubMed ID: 18368906
[TBL] [Abstract][Full Text] [Related]
6. The effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy: a randomized clinical trial.
Akefi R; Hashemi SM; Alinejad S; Almasi-Hashiani A
J Matern Fetal Neonatal Med; 2022 Nov; 35(21):4075-4080. PubMed ID: 33225772
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With Phototherapy.
Honar N; Ghashghaei Saadi E; Saki F; Pishva N; Shakibazad N; Hosseini Teshnizi S
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):97-100. PubMed ID: 26020375
[TBL] [Abstract][Full Text] [Related]
8. Treatment of obstructive jaundice in erythroblastosis fetalis with ursodeoxycholic acid (UDCA): a case report.
Perez EM; Cooper TR; Moise AA; Ferry GD; Weisman LE
J Perinatol; 1998; 18(4):317-9. PubMed ID: 9730206
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the effect of ursodeoxycholic acid on total bilirubin of neonates with glucose-6-phosphate dehydrogenase deficiency complicated by indirect hyperbilirubinaemia.
Rezaie M; Gholami R; Jafari M; Haghighinejad H
J Paediatr Child Health; 2021 Aug; 57(8):1175-1181. PubMed ID: 33682983
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.
Treeprasertsuk S; Silachamroon U; Krudsood S; Huntrup A; Suwannakudt P; Vannaphan S; Wilairatana P
J Gastroenterol Hepatol; 2010 Feb; 25(2):362-8. PubMed ID: 19817958
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholic acid treatment on essential fatty acid deficiency in patients with biliary atresia.
Yamashiro Y; Ohtsuka Y; Shimizu T; Nittono H; Urao M; Miyano T; Kawakami S; Hayasawa H
J Pediatr Surg; 1994 Mar; 29(3):425-8. PubMed ID: 8201513
[TBL] [Abstract][Full Text] [Related]
12. The effects of ursodeoxycholic acid in patients with severe obstructive jaundice after drainage procedure.
Hsu SH; Lu CL; Chan CY; Lin SH; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Sep; 60(3):142-6. PubMed ID: 9419950
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice.
Pelletier G; Roulot D; Davion T; Masliah C; Causse X; Oberti F; Raabe JJ; Van Lemmens C; Labadie H; Serfaty L;
Hepatology; 2003 Apr; 37(4):887-92. PubMed ID: 12668982
[TBL] [Abstract][Full Text] [Related]
14. Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice.
Maruo Y; Morioka Y; Fujito H; Nakahara S; Yanagi T; Matsui K; Mori A; Sato H; Tukey RH; Takeuchi Y
J Pediatr; 2014 Jul; 165(1):36-41.e1. PubMed ID: 24650397
[TBL] [Abstract][Full Text] [Related]
15. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
16. Breast Milk Constituents and the Development of Breast Milk Jaundice in Neonates: A Systematic Review.
Gao C; Guo Y; Huang M; He J; Qiu X
Nutrients; 2023 May; 15(10):. PubMed ID: 37242142
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
[TBL] [Abstract][Full Text] [Related]
18. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns.
Alpay F; Sarici SU; Tosuncuk HD; Serdar MA; Inanç N; Gökçay E
Pediatrics; 2000 Aug; 106(2):E16. PubMed ID: 10920172
[TBL] [Abstract][Full Text] [Related]
19. Urinary tract infections in infants: comparison between those with conjugated vs unconjugated hyperbilirubinaemia.
Lee HC; Fang SB; Yeung CY; Tsai JD
Ann Trop Paediatr; 2005 Dec; 25(4):277-82. PubMed ID: 16297302
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
